Long-Term Outcomes after Video-Assisted Thoracoscopic Pericardiectomy for Pericardial Effusion
| Autor: | Keishi Kondo, Jun Arikura, Hirofumi Adachi, Nobuhito Ueda, Yasushi Mizukami |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male Pulmonary and Respiratory Medicine medicine.medical_specialty Time Factors medicine.medical_treatment Clinical Decision-Making Kaplan-Meier Estimate 030204 cardiovascular system & hematology Malignancy Pericardial effusion Pericardial Effusion Young Adult 03 medical and health sciences 0302 clinical medicine Breast cancer Recurrence Risk Factors Neoplasms medicine Long term outcomes Humans Video assisted Young adult Pericardiectomy Aged Aged 80 and over Performance status Thoracic Surgery Video-Assisted business.industry Patient Selection Gastroenterology General Medicine Middle Aged medicine.disease Surgery Treatment Outcome 030228 respiratory system Original Article Female Cardiology and Cardiovascular Medicine business |
| Zdroj: | Annals of Thoracic and Cardiovascular Surgery. 23:304-308 |
| ISSN: | 2186-1005 1341-1098 |
| DOI: | 10.5761/atcs.oa.17-00046 |
| Popis: | Purpose Chronic or recurrent pericardial effusion is often associated with malignant disease. However, there have been few reports of the long-term outcomes after video-assisted thoracoscopic (VATS) pericardiectomy. We have performed it since 1992, and report our procedure and outcomes. Methods Patients who underwent VATS pericardiectomy were investigated. Results In all, 29 patients (12 men; median age: 61 (23-88) years) were evaluated; 8 had no malignancies and 21 did. Preoperative performance status (PS) scores were as follows: 1, 11 patients; 2, 10 patients; 3, 5 patients; and 4, 2 patients. One patient with malignancy died intraoperatively. PS improved significantly after the procedure (p = 0.0163). Median survival times were 5360 days in the nonmalignant group, 160 days in the malignant group, 209 days in breast cancer patients, and 62 days in other malignancy patients. The nonmalignant group had significantly longer survival than the malignant group (p = 0.0015). Most cases had uneventful postoperative courses. No recurrent pericardial effusions have been observed. Conclusion In cases of nonmalignant pericardial effusion, long-term survival is expected following VATS pericardiectomy. Malignant pericardial effusion has a poor prognosis, but most cases maintain good PS. However, early postoperative death may occur, and it is important to select patients carefully. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|